SummitTX Capital »

Inhibrx Biosciences shares owned by SummitTX Capital

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.8M 54k 33.68

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Cisco Systems (CSCO)
MKS Instruments (MKSI)
NVIDIA Corporation (NVDA)
Cyberark Software SHS (CYBR)
PPL Corporation (PPL)
Meritage Homes Corporation (MTH)
Toll Brothers (TOL)
Teradyne (TER)
Applied Materials (AMAT)
Griffon Corporation (GFF)
Owens Corning (OC)

View all positions for SummitTX Capital

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
Sanofi
HighTower Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Woodline Partners
Millennium Management
Partner Fund Management
Caligan Partners
Geode Capital Management
State Street Corporation
Readystate Asset Management
Kennedy Capital Management

View all funds holding Inhibrx Biosciences